"Driven by Rising Chronic Disease Burden and Breakthrough FDA Approvals, Biopharmaceutical Market Surges with Demand for Monoclonal Antibodies, Gene and Cell Therapies, and Innovative...
"Driven by Rising Chronic Disease Burden and Breakthrough FDA Approvals, Biopharmaceutical Market Surges with Demand for Monoclonal Antibodies, Gene and Cell Therapies, and Innovative...
Discover the future of Cannabis-Induced Psychosis (CIP) with the latest Pipeline Insight 2025 report. Gain in-depth analysis of CIP therapeutic developments, from early to marketed stages, including collaboration trends, licensing deals, and clinical trials. Navigate key players, active projects, and market growth strategies within the evolving CIP landscape.
Discover the future of Cannabis-Induced Psychosis (CIP) with the latest Pipeline Insight 2025 report. Gain in-depth analysis of CIP therapeutic developments, from early to marketed stages, including collaboration trends, licensing deals, and clinical trials. Navigate key players, active projects, and market growth strategies within the evolving CIP landscape.
The ROR inhibitors market is witnessing steady growth driven by the increasing understanding of receptor tyrosine kinase-like orphan receptor (ROR) pathways in cancer and...
The ROR inhibitors market is witnessing steady growth driven by the increasing understanding of receptor tyrosine kinase-like orphan receptor (ROR) pathways in cancer and...
While the current MCR therapy market is dominated by high-value, niche indications, the emerging pipeline is positioned to expand the class into mainstream disorders....
While the current MCR therapy market is dominated by high-value, niche indications, the emerging pipeline is positioned to expand the class into mainstream disorders....
OSLO, Norway (8 July 2025) – TGS ASA (“TGS”), a leading global provider of energy data and intelligence, routinely publishes a quarterly operational update six working days after quarter-end. For Q2 2025, it also includes a financial update.